Stay updated on Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Sign up to get notified when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.

Latest updates to the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check28 days agoChange DetectedThe page no longer displays the general government funding/operating status notice. The study content and participation information remain unchanged.SummaryDifference0.3%

- Check42 days agoChange DetectedNo additions or deletions were detected between the screenshots; the page content and layout appear unchanged.SummaryDifference0.4%

- Check71 days agoChange DetectedCore content updated with a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedUpdated to Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while keeping the revision label as the primary addition.SummaryDifference0.4%

- Check93 days agoChange DetectedThe page now shows Revision: v3.0.2 instead of v3.0.1; the 'Back to Top' link has been removed as a minor UI change.SummaryDifference0.2%

Stay in the know with updates to Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.